• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza vaccination situation in Middle-East and North Africa countries: Report of the 7th MENA Influenza Stakeholders Network (MENA-ISN)

tetano

Editor, Senior Moderator
J Infect Public Health. 2018 Aug 17. pii: S1876-0341(18)30107-2. doi: 10.1016/j.jiph.2018.07.003. [Epub ahead of print]
[h=1]Influenza vaccination situation in Middle-East and North Africa countries: Report of the 7th MENA Influenza Stakeholders Network (MENA-ISN).[/h] Al Awaidi S[SUP]1[/SUP], Abusrewil S[SUP]2[/SUP], AbuHasan M[SUP]3[/SUP], Akcay M[SUP]4[/SUP], Aksakal FNB[SUP]5[/SUP], Bashir U[SUP]6[/SUP], Elahmer O[SUP]7[/SUP], Esteghamati A[SUP]8[/SUP], Gahwagi M[SUP]9[/SUP], Mirza YK[SUP]10[/SUP], Grasso C[SUP]11[/SUP], Kassianos G[SUP]12[/SUP], Khris M[SUP]13[/SUP], Mardani M[SUP]14[/SUP], Maltezou H[SUP]15[/SUP], Nourlil J[SUP]16[/SUP], Oumzil H[SUP]17[/SUP], Osterhaus A[SUP]18[/SUP], Picot V[SUP]19[/SUP], Pehlivan T[SUP]4[/SUP], Saadatian-Elahi M[SUP]20[/SUP], Tali İ[SUP]13[/SUP], Tarraf H[SUP]21[/SUP], Ugur B[SUP]4[/SUP], Zaraket H[SUP]22[/SUP]; 7th MENA-ISN study group.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] The Middle East and North Africa (MENA) region faces a dual challenge with regard to influenza infection due to severe zoonotic influenza outbreaks episodes and the circulation of Northern Hemisphere human influenza viruses among pilgrims.
[h=4]METHODS:[/h] The MENA Influenza Stakeholder Network (MENA-ISN) was set-up with the aim of increasing seasonal influenza vaccination coverage by (i) enhancing evidence-based exchanges, and (ii) increasing awareness on the safety and benefits of seasonal vaccination. During the 7th MENA-ISN meeting, representatives from 8 countries presented their influenza surveillance, vaccination coverage and actions achieved and provided a list of country objectives for the upcoming 3 years.
[h=4]RESULTS:[/h] MENA-ISN countries share the goal to reduce influenza related morbidity and mortality. Participants admitted that lack of knowledge about influenza, its consequences in terms of morbidity, mortality and economy are the major barrier to attaining higher influenza vaccination coverage in their countries. The cost of the vaccine is another key barrier that could contribute to low vaccination coverage. Participants drew a list of strategic interventions to bridge gaps in the knowledge of influenza burden in this region.
[h=4]CONCLUSIONS:[/h] Participating countries concluded that despite an increase in vaccine uptake observed during the last few years, influenza vaccination coverage remains relatively low. Priority areas should be identified and action plans tailored to each country situation set-up to investigate the best way to move forward.
Copyright ? 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.


[h=4]KEYWORDS:[/h] Influenza; Middle East and North Africa; Surveillance; Vaccination coverage

PMID: 30126699 DOI: 10.1016/j.jiph.2018.07.003
 
Back
Top Bottom